Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v1-EN
Language French English
Date Updated 2020-06-11 2020-06-11
Drug Identification Number 02275023 02275023
Brand name TEVA-VENLAFAXINE XR TEVA-VENLAFAXINE XR
Common or Proper name VENLAFAXINE XR 37.5MG CAP VENLAFAXINE XR 37.5MG CAP
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients VENLAFAXINE VENLAFAXINE
Strength(s) 37.5MG 37.5MG
Dosage form(s) CAPSULE (EXTENDED RELEASE) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 100
ATC code N06AX N06AX
ATC description ANTIDEPRESSANTS ANTIDEPRESSANTS
Reason for discontinuation Other (Please describe in comments) Other (Please describe in comments)
Anticipated discontinuation date
Actual discontinuation date 2020-06-08 2020-06-08
Remaining supply date 2020-06-08 2020-06-08
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Information on remaining supply
Company comments Transitioned TEVA product to ACT-VENLAFAXINE. Transitioned TEVA product to ACT-VENLAFAXINE.
Health Canada comments